SCHEMBL669599

SCHEMBL669599

CCCCCC1CCCC1O

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.65
CA2 P00918 1/20 0.65
CA4 P22748 1/20 0.65
LSS P48449 2/20 0.42
ALOX5 P09917 1/20 0.40
GBA1 P04062 4/20 0.39
GUSB P08236 1/20 0.38
EPHX1 P07099 1/20 0.38
CYP1A2 P05177 1/20 0.37
S1PR2 O95136 1/20 0.37
S1PR4 O95977 1/20 0.37
S1PR1 P21453 1/20 0.37
S1PR3 Q99500 1/20 0.37
S1PR5 Q9H228 1/20 0.37
GLB1 P16278 3/20 0.36
GBA2 Q9HCG7 2/20 0.36
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL694436 1.00 CA1 (0.65) CA1CA2CA4LSSALOX5
SCHEMBL1391670 1.00 CA1 (0.65) CA1CA2CA4LSSALOX5
SCHEMBL30879546 1.00 CA1 (0.65) CA1CA2CA4LSSALOX5
SCHEMBL16766705 0.98 CA1 (0.63) CA1CA2CA4LSSALOX5
SCHEMBL16766627 0.98 CA1 (0.63) CA1CA2CA4LSSALOX5
SCHEMBL23542639 0.98 CA1 (0.63) CA1CA2CA4LSSALOX5
SCHEMBL19338297 0.98 CA1 (0.63) CA1CA2CA4LSSALOX5
SCHEMBL8754572 0.96 CA1 (0.72) CA1CA2CA4LSSALOX5
SCHEMBL8754576 0.96 CA1 (0.72) CA1CA2CA4LSSALOX5
SCHEMBL5557539 0.96 CA1 (0.72) CA1CA2CA4LSSALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 569 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4711010-A2 PRO-PERFUME COMPOSITIONS Firmenich SA (CH) 2026-03-18 EP claimed
US-RE50800-E1 Pro-fragrance compounds FIRMENICH SA (CH) 2026-02-17 US claimed
US-12509482-B2 3′-ketoglycoside compound for the slow release of a volatile alcohol GLYCOSCIENCE, S.L. (ES) 2025-12-30 US claimed
US-12404479-B2 Laundry detergent composition containing graft copolymer and benefit agent THE PROCTER & GAMBLE COMPANY (US) 2025-09-02 US claimed
EP-4555060-A1 LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT The Procter & Gamble Company (US) 2025-05-21 EP claimed
CN-115427421-B 3' -Ketoglycoside compounds for slow release of volatile alcohols 格莱克科学有限公司 2025-04-01 CN claimed
EP-4519404-A1 METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN Firmenich SA (CH) 2025-03-12 EP claimed
US-12234253-B2 Silicone compounds with a substituted amine group and a benefit agent moiety THE PROCTER & GAMBLE COMPANY (US) 2025-02-25 US claimed
US-20250051370-A1 SILICONE COMPOUNDS PROCTER & GAMBLE (US) 2025-02-13 US claimed
CN-119403908-A Method for enhancing psychological performance and composition for use in the method 弗门尼舍有限公司 2025-02-07 CN claimed
EP-2708592-A1 Fabric care composition The Procter & Gamble Company (US) 2014-03-19 EP claimed
EP-2694022-A2 COSMETIC COMPOSITION INCLUDING A CUCURBIC ACID COMPOUND AND A MIXTURE OF SULFONIC AND ACRYLIC POLYMERS L'OREAL (FR) 2014-02-12 EP claimed
EP-2515838-A1 COSMETIC COMPOSITION COMPRISING A JASMONIC ACID COMPOUND L'Oréal (FR) 2012-10-31 EP claimed
WO-2012143645-A2 COSMETIC COMPOSITION INCLUDING A CUCURBIC ACID COMPOUND AND A MIXTURE OF SULFONIC AND ACRYLIC POLYMERS L'OREAL (FR) 2012-10-26 WO claimed
EP-2430140-A2 PERFUME SYSTEMS The Procter & Gamble Company (US) 2012-03-21 EP claimed
EP-2345402-A1 Cosmetic cleansing composition comprising a derivative of jasmonic acid and a surface active agent L'Oréal (FR) 2011-07-20 EP claimed
WO-2011083235-A1 COSMETIC COMPOSITION COMPRISING A JASMONIC ACID COMPOUND L'OREAL (FR) 2011-07-14 WO claimed
WO-2011001111-A2 USE OF JASMONIC ACID TO TREAT OILY SKIN L'OREAL (FR) 2011-01-06 WO claimed
WO-2010132531-A2 PERFUME SYSTEMS THE PROCTER & GAMBLE COMPANY (US) 2010-11-18 WO claimed
US-20100287710-A1 PERFUME SYSTEMS THE PROCTER & GAMBLE COMPANY 2010-11-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051370-A1 SILICONE COMPOUNDS SMCHD1, SRI, SMS CA1 4159/4885CA2 4685/4885CA4 2687/4885
US-12234253-B2 Silicone compounds with a substituted amine group and a benefit agent moiety SMS, SRM, AAAS CA1 4078/4885CA2 4786/4885CA4 3259/4885
US-12509482-B2 3′-ketoglycoside compound for the slow release of a volatile alcohol EBP, MGAT1, MGAT3 CA1 2954/4885CA2 2724/4885CA4 3203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.